FindTrial
Sign In

Studying the educational package based on Iranian medicine in the prevention of neonatal jaundice

Investigating the effect of the educational package of Iranian medicine in the prevention of neonatal jaundice

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20230225057535N1
Enrollment
100
Registered
2023-06-08
Start date
2023-08-06
Completion date
Unknown
Last updated
2023-06-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Neonatal jaundice. Neonatal jaundice, unspecified

Interventions

Intervention group: The intervention group: will receive trainings related to diet in person and in a package.

Sponsors

Fasa University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: Women in the 32nd week of pregnancy, consent to participate in the study, not having allergies to the recommended foods

Exclusion criteria

Exclusion criteria: Lack of consent to participate in the study

Design outcomes

Primary

MeasureTime frame
Comparison bilirubin levels in intervention and control groups on 3, 6, 9, 12,15, and 20 days after delivery. Timepoint: Normal bilirubin level in newborns. Method of measurement: The blood sample of the newborn in the heel part of the intervention and control group will be taken by a trained nurse during 3, 6, 9, 12, 15, and 20 days after birth in the hospital, and bilirubin levels will be measured in the reference laboratory.—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactElham Haghjoo

Fasa University of Medical Sciences

mahsa_59_2007@yahoo.com+98 917 712 2336

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026